BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31268734)

  • 1. In-Bore Transrectal MRI-Guided Biopsy With Robotic Assistance in the Diagnosis of Prostate Cancer: An Analysis of 57 Patients.
    Barral M; Lefevre A; Camparo P; Hoogenboom M; Pierre T; Soyer P; Cornud F
    AJR Am J Roentgenol; 2019 Oct; 213(4):W171-W179. PubMed ID: 31268734
    [No Abstract]   [Full Text] [Related]  

  • 2. Robotic-assisted transrectal MRI-guided biopsy. Technical feasibility and role in the current diagnosis of prostate cancer: an initial single-center experience.
    Vilanova JC; Pérez de Tudela A; Puig J; Hoogenboom M; Barceló J; Planas M; Sala S; Thió-Henestrosa S
    Abdom Radiol (NY); 2020 Dec; 45(12):4150-4159. PubMed ID: 32705314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.
    Quentin M; Blondin D; Arsov C; Schimmöller L; Hiester A; Godehardt E; Albers P; Antoch G; Rabenalt R
    J Urol; 2014 Nov; 192(5):1374-9. PubMed ID: 24866597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of histological findings obtained combining US/mp-MRI fusion-guided biopsies with systematic US biopsies: mp-MRI role in prostate cancer detection and false negative.
    Faiella E; Santucci D; Greco F; Frauenfelder G; Giacobbe V; Muto G; Zobel BB; Grasso RF
    Radiol Med; 2018 Feb; 123(2):143-152. PubMed ID: 29019021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-Bore MRI-guided Prostate Biopsies: Retrospective Observational Study of Complementary Nontargeted Sampling of Normal-appearing Areas at Multiparametric MRI.
    Elfatairy KK; Filson CP; Sanda MG; Osunkoya AO; Nour SG
    Radiol Imaging Cancer; 2019 Nov; 1(2):e190016. PubMed ID: 33778681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted MRI-guided prostate biopsy: are two biopsy cores per MRI-lesion required?
    Schimmöller L; Quentin M; Blondin D; Dietzel F; Hiester A; Schleich C; Thomas C; Rabenalt R; Gabbert HE; Albers P; Antoch G; Arsov C
    Eur Radiol; 2016 Nov; 26(11):3858-3864. PubMed ID: 26920391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of MRI-Targeted in-Bore Prostate Biopsy According to the Gleason Score with Postprostatectomy Histopathologic Control--a Targeted Biopsy-Only Strategy with Limited Number of Cores.
    Garmer M; Busch M; Mateiescu S; Fahlbusch DE; Wagener B; Grönemeyer DH
    Acad Radiol; 2015 Nov; 22(11):1409-18. PubMed ID: 26343218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI-Guided In-Bore Biopsy: Differences Between Prostate Cancer Detection and Localization in Primary and Secondary Biopsy Settings.
    Schimmöller L; Blondin D; Arsov C; Rabenalt R; Albers P; Antoch G; Quentin M
    AJR Am J Roentgenol; 2016 Jan; 206(1):92-9. PubMed ID: 26700339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast 3-T MR-guided transrectal prostate biopsy using an in-room tablet device for needle guide alignment: a feasibility study.
    Overduin CG; Heidkamp J; Rothgang E; Barentsz JO; de Lange F; Fütterer JJ
    Eur Radiol; 2018 Nov; 28(11):4824-4831. PubMed ID: 29789909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "In-bore" MRI-guided Prostate Biopsy Using an Endorectal Nonmagnetic Device: A Prospective Study of 70 Consecutive Patients.
    Schiavina R; Vagnoni V; D'Agostino D; Borghesi M; Salvaggio A; Giampaoli M; Pultrone CV; Saraceni G; Gaudiano C; Vigo M; Bianchi L; Dababneh H; La Manna G; Chessa F; Romagnoli D; Martorana G; Brunocilla E; Porreca A
    Clin Genitourin Cancer; 2017 Jun; 15(3):417-427. PubMed ID: 28258961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of magnetic resonance imaging-guided biopsy for diagnosis of prostate cancer; comparison between FUSION and "IN-BORE" approaches.
    D'Agostino D; Casablanca C; Mineo Bianchi F; Corsi P; Romagnoli D; Giampaoli M; Fiori C; Schiavina R; Brunocilla E; Artibani W; Porreca A
    Minerva Urol Nephrol; 2021 Feb; 73(1):90-97. PubMed ID: 32456413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Cancer Detection Rates Between TRUS-Guided Biopsy and MRI-Targeted Biopsy According to PSA Level in Biopsy-Naive Patients: A Propensity Score Matching Analysis.
    Choi YH; Kang MY; Sung HH; Jeon HG; Chang Jeong B; Seo SI; Jeon SS; Kim CK; Park BK; Lee HM
    Clin Genitourin Cancer; 2019 Feb; 17(1):e19-e25. PubMed ID: 30415878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy-Are 2 Biopsy Cores per Magnetic Resonance Imaging Lesion Required?
    Dimitroulis P; Rabenalt R; Nini A; Hiester A; Esposito I; Schimmöller L; Antoch G; Albers P; Arsov C
    J Urol; 2018 Nov; 200(5):1030-1034. PubMed ID: 29733837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Yield of Incremental Biopsy Cores and Second Lesion Sampling for In-Gantry MRI-Guided Prostate Biopsy.
    Seyfried N; Mahran A; Panda A; Obmann VC; Buzzy CA; Jiang Y; Wright KL; Nakamoto DA; Patel IJ; Conroy B; Ponsky L; Gulani V
    AJR Am J Roentgenol; 2021 Oct; 217(4):908-918. PubMed ID: 33336582
    [No Abstract]   [Full Text] [Related]  

  • 15. In-bore magnetic resonance-guided transrectal biopsy for the detection of clinically significant prostate cancer.
    Felker ER; Lee-Felker SA; Feller J; Margolis DJ; Lu DS; Princenthal R; May S; Cohen M; Huang J; Yoshida J; Greenwood B; Kim HJ; Raman SS
    Abdom Radiol (NY); 2016 May; 41(5):954-62. PubMed ID: 27118268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI-directed high-frequency (29MhZ) TRUS-guided biopsies: initial results of a single-center study.
    Cornud F; Lefevre A; Flam T; Dumonceau O; Galiano M; Soyer P; Camparo P; Barral M
    Eur Radiol; 2020 Sep; 30(9):4838-4846. PubMed ID: 32350662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-bore biopsies of the prostate assisted by a remote-controlled manipulator at 1.5 T.
    Linder N; Schaudinn A; Petersen TO; Bailis N; Stumpp P; Horn LC; Stolzenburg JU; Kahn T; Moche M; Busse H
    MAGMA; 2019 Oct; 32(5):599-605. PubMed ID: 31073867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abbreviated Biparametric Prostate MR Imaging in Men with Elevated Prostate-specific Antigen.
    Kuhl CK; Bruhn R; Krämer N; Nebelung S; Heidenreich A; Schrading S
    Radiology; 2017 Nov; 285(2):493-505. PubMed ID: 28727544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Real-time MRI/US fusion-guided biopsy in biopsy-naïve and pre-biopsied patients with suspicion for prostate cancer].
    Maxeiner A; Stephan C; Fischer T; Durmus T; Kilic E; Asbach P; Haas M; Günzel K; Neymeyer J; Miller K; Cash H
    Aktuelle Urol; 2015 Jan; 46(1):34-8. PubMed ID: 25519051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.